Dr. DiMarco does research for Medtronic, is a consultant for Medtronic, Novartis, and St. Jude, and is a speaker for Boston Scientific.SOURCE:
Groenveld HF, et al. Rate control efficacy in permanent atrial fibrillation: Successful and failed strict rate control against a background of lenient rate control. Data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). J Am Coll Cardiol 2013;61:741-778.